Cognitive behavioural therapy (CBT) intervention delivered by respiratory nurses is effective in reducing anxiety symptoms and utilisation of healthcare resources in patients with chronic obstructive pulmonary disease (COPD), thus providing a cost-effective strategy for treating anxiety — a symptom often comorbid with COPD, according to a study.
The addition of mirtazapine to serotonin-noradrenaline (SNRI) or selective serotonin reuptake inhibitor (SSRI) does not provide a clinically significant benefit compared with placebo in a treatment-resistant group of primary care patients with depression, a study has shown.
Chronic noncancer pain can be treated with the use of opioid without necessarily causing addiction or abuse by the patient, according to a study presented at the Singapore Health and Biomedical Congress (SHBC) 2018.
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
Compelling evidence indicates weight bias, in which obese students appear to do less well in tertiary education than their healthy weight peers, according to a systematic review. University/college attainment appears to be less impacted by socioeconomic factors than school-based achievement.
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.